Literature DB >> 32128971

Physical Function, Physical Activity, and Quality of Life After Liver Transplantation.

Michael A Dunn1,2,3, Shari S Rogal4,5, Andres Duarte-Rojo1,2,3, Jennifer C Lai6.   

Abstract

Robust physical activity after liver transplantation is an important determinant of longterm health, similar in its importance to the value of pretransplant activity for withstanding the immediate stress of transplantation. Although transplantation normally enables rapid recovery of liver synthetic and metabolic functions, the recovery of physical capacity and performance to normal levels is delayed and often incomplete. Anatomic measurements of sarcopenia and the physical performance indicators of frailty both tend to improve slowly, and they may, in fact, decrease further in the posttransplant period, especially when the common extrahepatic drivers of muscle loss, such as the elements of the metabolic syndrome, persist or intensify after transplantation. Posttransplant exercise improves fitness, which is a conclusion based on 2 observational studies and 3 randomized trials that assessed endpoints of strength testing, energy expenditure in metabolic equivalents, and peak or maximal oxygen uptake. Importantly, 1 controlled trial found that exercise also improved quality of life (QOL) measured by the Short Form 36 survey, consistent with multiple reports of the value of social support and engagement in sports activity for improving posttransplant QOL. Developing evidence-based standards for post-liver transplant physical activity baseline testing and sustainment of intensity and quality is a key unmet need in transplant hepatology. At present, it is reasonable for transplant teams to assess fitness and design a tailored exercise program when a recipient is first discharged, to record and reinforce progress at all posttransplant visits, and to set realistic longterm performance goals that will often achieve recommended standards for the healthy general population.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32128971      PMCID: PMC8063858          DOI: 10.1002/lt.25742

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  41 in total

1.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.

Authors:  Elizabeth J Carey; Jennifer C Lai; Christopher Sonnenday; Elliot B Tapper; Puneeta Tandon; Andres Duarte-Rojo; Michael A Dunn; Cynthia Tsien; Eric R Kallwitz; Vicky Ng; Srinivasan Dasarathy; Matthew Kappus; Mustafa R Bashir; Aldo J Montano-Loza
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

Review 2.  Quality of life after liver transplantation. A systematic review.

Authors:  Santiago Tome; Jennifer T Wells; Adnan Said; Michael R Lucey
Journal:  J Hepatol       Date:  2008-01-28       Impact factor: 25.083

Review 3.  Effects of Exercise and Sport in Solid Organ Transplant Recipients: A Review.

Authors:  Jill Neale; Alice C Smith; Nicolette C Bishop
Journal:  Am J Phys Med Rehabil       Date:  2017-04       Impact factor: 2.159

4.  The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates.

Authors:  Michael A Dunn; Deborah A Josbeno; Amy R Schmotzer; Amit D Tevar; Andrea F DiMartini; Douglas P Landsittel; Anthony Delitto
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

5.  Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.

Authors:  Cynthia Tsien; Ari Garber; Arvind Narayanan; Shetal N Shah; David Barnes; Bijan Eghtesad; John Fung; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

6.  The effect of liver transplantation on patient-centred outcomes: a propensity-score matched analysis.

Authors:  Kenneth A McLean; Thomas M Drake; Alessandro Sgrò; Julian Camilleri-Brennan; Stephen R Knight; Riinu Ots; Anya Adair; Stephen J Wigmore; Ewen M Harrison
Journal:  Transpl Int       Date:  2019-03-20       Impact factor: 3.782

7.  Combined resistance and endurance training at a moderate-to-high intensity improves physical condition and quality of life in liver transplant patients.

Authors:  Diego Moya-Nájera; Ángel Moya-Herraiz; Luis Compte-Torrero; David Hervás; Sebastien Borreani; Joaquin Calatayud; Marina Berenguer; Juan C Colado
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

8.  Fatigue after liver transplantation: effects of a rehabilitation program including exercise training and physical activity counseling.

Authors:  Rita J G van den Berg-Emons; Berbke T J van Ginneken; Carla F J Nooijen; Herold J Metselaar; Huug W Tilanus; Geert Kazemier; Henk J Stam
Journal:  Phys Ther       Date:  2014-02-20

9.  Physical activity and metabolic syndrome in liver transplant recipients.

Authors:  Eric R Kallwitz; Veronica Loy; Praveen Mettu; Natasha Von Roenn; Jamie Berkes; Scott J Cotler
Journal:  Liver Transpl       Date:  2013-08-15       Impact factor: 5.799

10.  Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.

Authors:  Gangarao Davuluri; Dawid Krokowski; Bo-Jhih Guan; Avinash Kumar; Samjhana Thapaliya; Dharmvir Singh; Maria Hatzoglou; Srinivasan Dasarathy
Journal:  J Hepatol       Date:  2016-06-16       Impact factor: 25.083

View more
  8 in total

1.  Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Andrea Gonzalez; Mayalen Valero-Breton; Camila Huerta-Salgado; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2021-03-26

2.  Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.

Authors:  Jennifer C Lai; Amy M Shui; Andres Duarte-Rojo; Daniel R Ganger; Robert S Rahimi; Chiung-Yu Huang; Frederick Yao; Matthew Kappus; Brian Boyarsky; Mara McAdams-Demarco; Michael L Volk; Michael A Dunn; Daniela P Ladner; Dorry L Segev; Elizabeth C Verna; Sandy Feng
Journal:  Hepatology       Date:  2021-12-29       Impact factor: 17.298

3.  Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

5.  Health-Related Quality of Life and Frailty in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Life (Basel)       Date:  2020-05-24

6.  Close Correlation between Frailty and Depressive State in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Medicina (Kaunas)       Date:  2020-06-27       Impact factor: 2.430

7.  Health-related quality of life, workability, and return to work of patients after liver transplantation.

Authors:  Christian Fazekas; Daniela Kniepeiss; Nora Arold; Franziska Matzer; Jolana Wagner-Skacel; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2021-05-06       Impact factor: 3.445

Review 8.  Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.

Authors:  Lukas Hartl; Joshua Elias; Gerhard Prager; Thomas Reiberger; Lukas W Unger
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.